Heparan sulfate upregulates platelet-derived growth factor receptors on human lung fibroblasts

Glycobiology

Volumn 8, Issue 12, 1998, Pages 1149-1155

  Malmström, Johan ^a   Westergren Thorsson, Gunilla ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Cell growth; Fibroblast; Heparan sulfate; Platelet derived growth factor; Platelet derived growth factor receptors

Indexed keywords

HEPARAN SULFATE; IODINE 125; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MITOGENICITY; PRIORITY JOURNAL;

CELL DIVISION; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; GENE EXPRESSION REGULATION; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; HUMANS; IDURONIC ACID; LUNG; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BINDING; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RNA, MESSENGER; UP-REGULATION;

TRIXIS;

EID: 0032417485     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/8.12.1149     Document Type: Article

References (39)

1. Arroyo-Yanguas, Y., Cheng, F., Isaksson, A., Fransson, L.-Å., Malmström, A. and Westergren-Thorsson, G. (1997) Binding, internalization, and degradation of anti-proliferative heparan sulfate by human embryonic lung cells. J. Cell. Biochem., 64, 595-604.
2. Aviezer, D., Levy, E., Safran, M., Svahn, C., Buddecke, E., Schmidt, A., David, G., Vlodavsky, I. and Yayon, A. (1994) Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J. Biol. Chem., 269, 114-121.
3. Betzholtz, C., Johnsson, A., Heldin, C.-H., Westermark, B., Lind, P., Urdea, M.S., Eddy, R., Shows, T.B., Philpot, K., Mellor, A.L., Knott, T.J. and Scott, J. (1986) cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature, 320, 69-99.
4. Bornfeldt, K.E., Raines, E.W., Graves, L.M., Skinner, M.P., Krebs, E.G. and Ross, R. (1995) Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann. NY Acad. Sci., 766, 416-430.
5. Busch, S.J., Martin, G.A., Barnhart, R.L., Mano, M., Cardin, A.D. and Jackson, R.L. (1992) Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription. J. Cell. Biol., 116, 31-42.
6. Castellot, J.J., Wong, K., Herman, H., Hoover, R.L., Albertini, D.F., Wright, T.C., Caleb, B.J. and Morrisk, J.K. (1985) Binding and internalization of heparin by vascular smooth muscle cells. J. Cell. Physiol., 124, 12-20.
7. Chomzynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium tiocyanate-phenol-chloroform extraction. Anal. Chem., 162, 156-159.
8. Claesson-Welsch, L., Eriksson, A., Westermark, B. and Heldin, C.-H. (1989) cDNA cloning and expression of human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type receptor. Proc. Natl. Acad. Sci. USA, 86, 4917-4921
9. Collins, T., Ginsburg, D., Boss, J.M., Orkin, S.H. and Pober, J.S. (1985) Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature, 316, 748-750.
10. Elenius, K., Vainia, S., Laato, M., Salmivirta, M., Thesleff, I. and Jalkanen, M. (1991) Induced expression of syndecan in healing wounds. J. Cell Biol., 114, 585-595.
11. Fedarko, N.S. and Conrad, H.E. (1986) A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells. J. Cell. Biol., 102, 587-599.
12. Feyzi, E., Lustig, F., Fager, G., Spillmann, D., Lindahl, U. and Salmivirta, M. (1997) Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain. J. Biol. Chem., 272, 5518-5524.
13. Floege, J., Eng, E., Young, B.A., Couser, W.G. and Johnson, R.J. (1993) Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int., 43, 369-380.
14. Fransson, L.-Å. and Sjöberg, L. (1980) Structural studies on heparan sulfates, characterization of oligosaccharides obtained by peroxidate-oxidation and alkaline elimination. Eur. J. Biochem., 106, 59-69.
15. Gilles, R.J., Didier, N. and Denton, M. (1986) Determination of cell number in monolayer cultures. Anal. Biochem., 159, 109-113.
16. Guimond, S., Maccarana, M., Olwin, B.B., Lindahl, U. and Rapraeger, A.C. (1993) Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem., 268, 23906-23914.
17. Heldin, C.-H. (1997) Simultaneous induction of stimulatory and inhibitory signals by PDGF- FEBS Lett., 410, 17-21.
18. Herbert, J.-M., Clowes, M., Lea, H.J, Pascal, M. and Clowes, A.W. (1996) Protein kinase C α expression is required for heparin inhibition of rat smooth muscle cell proliferation in vitro and in vivo. J. Biol. Chem., 271, 25928-25935.
19. Hiscock, D.R.R., Yanagashita, M. and Hascall, V.C. (1994) Nuclear localization of glycosaminoglycans in rat ovarian granulosa cells. J. Biol. Chem., 269, 4539-4546.
20. Huang, J.S., Huang, S.S., Kennedy, B. and Deuel, T.F. (1981) Platelet-derived growth factor specific binding to target cells. J. Biol. Chem., 14, 8130-8136.
21. Kelly, J.L., Sanchez, A., Brown, G.S., Chesterman, C.N. and Sleigh, M. (1993) Accumulation of PDGF B and cell-binding forms of PDGF A in the extracellular matrix. J. Cell. Biol., 121, 1153-1163.
22. 2-macroglobulin complex up-regulate the platelet-derived growth factor α-receptor on rat pulmonary fibroblasts. Am J. Respir. Cell Mol. Biol., 13, 455-465.
23. Maccarana, M., Casu, B. and Lindahl, U. (1993) Minimal sequence in heparin/heparan sulfate requried for binding of basic fibroblast growth factor. J. Biol. Chem., 268, 23989-23905.
24. Miralem, T., Wang, A., Whiteside, C.I. and Templeton, D.M. (1996) Heparin inhibits mitogen-activated protein kinase-dependent and -independent c-fos induction in mesengial cells. J. Biol. Chem., 29, 17100-17106.
25. Ottlinger, M.E., Pukac, L.A. and Karnovsky, M.J. (1993) Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. J. Biol. Chem., 268, 19173-19176.
26. Pukac, L.A., Castellot, J.J., Jr., Wright, T.C. Jr., Caleb, B.L. and Karnovsky, M.J. (1990) Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regulation, 1, 435-443.
27. Pukac, L.A., Carter, J.E., Ottlinger, M.E. and Karnovsky, M.J. (1997) Mechanisms of inhibition by heparin of PDGF-stimulated MAP kinase activation in vascular smooth muscle cells. J. Cell. Physiol., 172, 69-78.
28. Raines, E.W. and Ross, R. (1992) Compartmentalization of PDGF on extracellular binding site dependent on exon-6-encoded sequences. J. Cell Biol., 116, 533-543.
29. Redini, F., Moczar, E., Antoine, E. and Poupon, M.F. (1989) Binding and internalization of exogenous glycosaminoglycans in weakly and highly metastatic rhabdomyosarcoma cells. Biochem. Biophys. Acta, 991, 359-366.
30. Ueda, Y., Hirai, S.-I., Osada, S.-I., Suzuki, A., Mizuno, K. and Ohno, S. (1996) Protein kinase δ activates the MEK-ERK pathway in a manner independent of Ras and dependent of Raf. J. Biol. Cehm., 271, 23512-23519.
31. Vannucchi, S., Pasquali, F., Porciatti, F., Chiarugi, V., Magnelli, L. and Bianchini, P. (1988) Binding, internalization anf degradation of heparin and heparin fragments by cultured endothelial cells. Thromb. Res., 49, 373-383.
32. Walker, A, Turnbull, J.E. and Gallagher, J.T. (1994): Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor J. Biol. Chem., 269, 931-935.
33. Westergren-Thorsson, G., Önnervik, P-O., Fransson, L.-Å. and Malmström, A. (1991) Proliferation of cultured fibroblasts is inhibited by 1-iduronate-containing glycosaminoglycans. J. Cell. Physiol., 147, 523-530.
34. Westergren-Thorsson, G., Persson, S., Isaksson, A., Önnervik, P-O., Malmström, A. and Fransson, L.-Å. (1993a) 1-Iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. Exp. Cell. Res., 206, 93-99.
35. Westergren-Thorsson, G., Hernnäs, J., Särnstrand, B., Oldberg, Å., Heinegård, D. and Malmström, A. (1993b) Altered expression of small proteoglycans, collagen, and transforming growth factor-β1 in developing bleomycin-induced pulmonary fibrosis in rats. J. Clin. Invest., 92, 632-637.
36. Wright, T.C., Castellot, J.J., Diamond, J.R. and Karnovsky, M.J. (1989a) Regulation of cellular proliferation of heparin and heparan sulfate. In Lane, D.A. and Lindahl, U. (eds.), Heparin. Edward Arnold, London, pp. 295-316.
37. Wright, T.C., Jr., Castellot, J.J., Jr., Petitou, M., Lormeau, J.-C., Choay, J. and Karnovsky, M.J. (1989b) Structural determinants of heparin's growth inhibitory activity. J. Biol. Chem., 264, 1534-1542.
38. Wright, T.C., Jr., Pukac, L.A., Castellot, J.J., Jr., Karnovsky, M.J., Levine, R.A., Kim-Park, H.-Y. and Camprisi, J. (1989c) Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc. Natl. Acad. Sci. USA, 86, 3199-3203.
39. Xu, J. and Clark, A.F.R. (1996) Extracellular matrix alters PDGF regulation of fibroblast integrins. J. Cell Biol., 132, 239-249.